Trademark: 87914539
Status Date
Thursday, June 16, 2022
Filing Date
Wednesday, May 9, 2018
Published for Opposition
Tuesday, December 11, 2018
Abandoned Date
Monday, June 6, 2022
5 diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical or veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids or tissue; kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection; medical diagnostic reagents for use relating to molecular identification and digital quantification
Jun 16, 2022
Abandonment Notice E-Mailed - Failure To Respond
Jun 16, 2022
Abandonment - Failure To Respond Or Late Response
Dec 3, 2021
Notification Of Non-Final Action E-Mailed
Dec 3, 2021
Non-Final Action E-Mailed
Dec 3, 2021
Su - Non-Final Action - Written
Aug 30, 2021
Assigned To Examiner
Aug 19, 2021
Assigned To Examiner
Aug 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2021
Statement Of Use Processing Complete
Aug 5, 2021
Use Amendment Filed
Aug 16, 2021
Sou Extension 5 Granted
Aug 5, 2021
Sou Extension 5 Filed
Aug 5, 2021
Sou Teas Extension Received
Aug 5, 2021
Teas Statement Of Use Received
Jan 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2021
Sou Extension 4 Granted
Jan 20, 2021
Sou Extension 4 Filed
Jan 20, 2021
Sou Teas Extension Received
Jul 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2020
Sou Extension 3 Granted
Jul 20, 2020
Sou Extension 3 Filed
Jul 20, 2020
Sou Teas Extension Received
Feb 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2020
Sou Extension 2 Granted
Jan 30, 2020
Sou Extension 2 Filed
Jan 30, 2020
Sou Teas Extension Received
Oct 29, 2019
Corrected Noa E-Mailed
Oct 28, 2019
Divisional Processing Complete
Oct 23, 2019
Divisional Request Received
Oct 25, 2019
Case Assigned To Intent To Use Paralegal
Oct 23, 2019
Teas Request To Divide Received
Oct 3, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 2, 2019
Sou Extension 1 Granted
Aug 5, 2019
Sou Extension 1 Filed
Oct 2, 2019
Case Assigned To Intent To Use Paralegal
Aug 15, 2019
Notice Of Revival - E-Mailed
Aug 15, 2019
Sou Extension Received With Teas Petition
Aug 15, 2019
Petition To Revive-Granted
Aug 15, 2019
Teas Petition To Revive Received
Feb 5, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 11, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 11, 2018
Published For Opposition
Nov 21, 2018
Notification Of Notice Of Publication E-Mailed
Nov 2, 2018
Law Office Publication Review Completed
Nov 2, 2018
Assigned To Lie
Oct 18, 2018
Approved For Pub - Principal Register
Oct 15, 2018
Teas/Email Correspondence Entered
Oct 14, 2018
Correspondence Received In Law Office
Oct 14, 2018
Teas Response To Office Action Received
Aug 31, 2018
Notification Of Priority Action E-Mailed
Aug 31, 2018
Priority Action E-Mailed
Aug 31, 2018
Priority Action Written
Aug 30, 2018
Assigned To Examiner
May 18, 2018
New Application Office Supplied Data Entered
May 12, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
